|Title||Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery.|
|Publication Type||Journal Article|
|Year of Publication||2020|
|Authors||Soubannier, Vincent, Gilles Maussion, Mathilde Chaineau, Veronika Sigutova, Guy Rouleau, Thomas M. Durcan, and Stefano Stifani|
|Date Published||2020 07 13|
Astrocytes play a number of key functions in health and disease. Activated astrocytes are present in most, if not all, neurological diseases. Most current information on the mechanisms underlying reactive astrocyte emergence derives from studies using animal experimental systems, mainly because the ability to study human astrocytes under healthy and pathological conditions has been hampered by the difficulty in obtaining primary human astrocytes. Here we describe robust and reliable derivation of astrocytes from human induced pluripotent stem cells (iPSCs). Phenotypically characterized human iPSC-derived astrocytes exhibit typical traits of physiological astrocytes, including spontaneous and induced calcium transients. Moreover, human iPSC-derived astrocytes respond to stimulation with a pro-inflammatory combination of tumor necrosis factor-alpha, interleukin 1-alpha, and complement component C1q by undergoing changes in gene expression patterns suggesting acquisition of a reactive astrocyte phenotype. Together, these findings provide evidence suggesting that human iPSC-derived astrocytes are a suitable experimental model system to study astrocyte function and reactivation in healthy and pathological conditions of the human nervous system.
|Alternate Journal||Neurosci Lett|
|Grant List||/ / CIHR / Canada|